The invention relates to an improved process for synthesis of anti-Parkinson compound from commercially available (R)-benzyl glycidyl ether, wherein the compound obtained has enantiopurity greater than >98%.
Filing Date: 02-11-2015
Issue Date: 25-10-2016
Applicant: CSIR-National Chemical Laboratory (CSIR-NCL), Pune
Patent No: US9475757
Application No: 14/888697
Inventor(s): Muthukrishnan Murugan; Mujahid Mohammad
